Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways

Experimental Dermatology

Volumn 15, Issue 7, 2006, Pages 538-546

  Kim, Arianna L ^a   Zhu, Yucui ^a   Zhu, Huijie ^a   Han, Lydia ^b   Kopelovich, Levy ^b   Bickers, David R ^a   Athar, Mohammad ^a  

^a Columbia University ^*  (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Activating protein 1; Cell cycle; Extracellular signal regulated protein kinase; Resveratrol

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MUTANT PROTEIN; PROTEIN C JUN; PROTEIN P53; RESVERATROL; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DIMERIZATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GENE EXPRESSION; HUMANS; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STILBENES; TRANSCRIPTION FACTOR AP-1;

EID: 33744831517     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00445.x     Document Type: Article

References (39)

1. Granados-Soto V. Pleiotropic effects of resveratrol. Drug News Perspect 2003: 16: 299-307.
2. Pace-Asciak C R, Rounova O, Hahn S E, Diamandis E P, Goldberg D M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996: 246: 163-182.
3. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon J M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997: 61: 2103-2110.
4. Jang D S, Kang B S, Ryu S Y, Chang I M, Min K R, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem Pharmacol 1999: 57: 705-712.
5. Aggarwal B B, Bhardwaj A, Aggarwal R S, Seeram N P, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004: 24: 2783-2840.
6. Jang M, Pezzuto J M. Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 1999: 25: 65-77.
7. Afaq F, Adhami V M, Ahmad N, Mukhtar H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci 2002: 7: d784-d792.
8. Afaq F, Mukhtar H. Photochemoprevention by botanical antioxidants. Skin Pharmacol Appl Skin Physiol 2002: 15: 297-306.
9. Kapadia G J, Azuine M A, Tokuda H et al. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res 2002: 45: 499-505.
10. Aziz M H, Reagan-Shaw S, Wu J, Longley B J, Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: Relevance to human disease? FASEB J 2005: 19: 1193-1195.
11. Marks R, Motley R J. Skin cancer. Recogn Treat Drugs 1995: 50: 48-61.
12. Saldanha G. The Hedgehog signalling pathway and cancer. J Pathol 2001: 193: 427-432.
13. Kim A L, Athar M, Bickers D R, Gautier J. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem Photobiol 2002: 75: 58-67.
14. Kim A L, Athar M, Bickers D R, Gautier J. Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53. J Invest Dermatol 2002: 118: 818-824.
15. Jonat C, Rahmsdorf H J, Park K K et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990: 62: 1189-1204.
16. Schreiber M, Kolbus A, Piu F et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999: 13: 607-619.
17. Smith M J, Prochownik E V. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood 1992: 79: 2107-2115.
18. Shaulian E, Schreiber M, Piu F, Beeche M, Wagner E F, Karin M. The mammalian UV response: C-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000: 103: 897-907.
19. Young M R, Li J J, Rincon M et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 1999: 96: 9827-9832.
20. Behrens A, Jochum W, Sibilia M, Wagner E F. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 2000: 19: 2657-2663.
21. Kurisaki K, Kurisaki A, Valcourt U et al. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol Cell Biol 2003: 23: 4494-4510.
22. Pan W, Sun T, Hoess R, Grafstrom R. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. Carcinogenesis 1998: 19: 765-769.
23. Grafstrom R H, Pan W, Hoess R H. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex. Carcinogenesis 1999: 20: 193-198.
24. Connell-Crowley L, Harper J W, Goodrich D W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 1997: 8: 287-301.
25. Dudley D T, Pang L, Decker S J, Bridges A J, Saltiel A R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 1995: 92: 7686-7689.
26. Favata M F, Horiuchi K Y, Manos E J et al. Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 1998: 273: 18623-18632.
27. English J M, Cobb M H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002: 23: 40-45.
28. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997: 9: 240-246.
29. Fujita N, Sato S, Tsuruo T. Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2003: 278: 49254-49260.
30. Yamasaki L. Role of the RB tumor suppressor in cancer. Cancer Treat Res 2003: 115: 209-239.
31. Suyama H, Igishi T, Sano H et al. ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells. Int J Oncol 2004: 24: 1499-1504.
32. Shi B, Isseroff R R. Epidermal growth factor (EGF)-mediated DNA-binding activity of AP-1 is attenuated in senescent human epidermal keratinocytes. Exp Dermatol 2005: 14: 519-527.
33. Yang S, Meyskens F L Jr. Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol Pharmacol 2005: 67: 298-308.
34. Kovary K, Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 1991: 11: 4466-4472.
35. Kovary K, Bravo R. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: In vitro and in vivo associations. Mol Cell Biol 1991: 11: 2451-2459.
36. Cosenza S C, Yumet G, Soprano D R, Soprano K J. Induction of c-fos and c-jun mRNA at the M/G1 border is required for cell cycle progression. J Cell Biochem 1994: 55: 503-512.
37. Herber B, Truss M, Beato M, Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 1994: 9: 2105-2107.
38. Albanese C, D'Amico M, Reutens A T et al. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 1999: 274: 34186-34195.
39. Brown J R, Nigh E, Lee R J et al. Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol 1998: 18: 5609-5619.